<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-122244</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Choroidal neovascularization secondary to angioid streaks: A familial case report</dc:title>
<dc:description xml:lang="en">Case report: We report a familial case of 2 brothers that suffered choroidal neovascularization (CNV) secondary to angioid streaks. They were both treated with a monthly intravitreal injection of ranibizumab (Lucentis®) for 3 months. Visual acuity was stabilized and fluorescein angiography revealed complete resolution of CNV. Neither recurrent CNV lesion nor new hemorrhages were reported during the follow-up period. Discussion: The use of intravitreal ranibizumab for the treatment of CNV in patients with angioid streaks has shown favorable results. However, further studies with a longer follow-up and larger number of patients are necessary to more precisely determine the results of this therapy (AU)</dc:description>
<dc:creator>Lopez-Guajardo, L</dc:creator>
<dc:creator>Camara-Gonzalez, C</dc:creator>
<dc:creator>Pareja-Esteban, J</dc:creator>
<dc:creator>Benitez-Herreros, J</dc:creator>
<dc:creator>Beckford-Torngren, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Se expone el caso de dos hermanos que presentaron neovascularización coroidea asociada a estrías angioides. Ambos pacientes fueron tratados con una inyección mensual de ranibizumab (Lucentis®) intravítrea durante tres meses. La visión se estabilizó y la angiografía fluoresceínica mostró resolución completa de la neovascularización coroidea. Durante el seguimiento, no observamos recurrencia del cuadro. Discusión: El uso de ranibizumab intravítreo en caso de neovascularización coroidea asociada a estrías angioides ha mostrado resultados favorables. No obstante, serán necesarias series de casos mayores que nos permitan conocer la verdadera eficacia de este tratamiento (AU)</dc:description>
<dc:source>Arch Soc Esp Oftalmol;89(5): 190-193, mayo 2014. ilus</dc:source>
<dc:identifier>ibc-122244</dc:identifier>
<dc:title xml:lang="es">Neovascularización coroidea secundaria a estrías angioides: un caso familiar</dc:title>
<dc:subject>^d11998^s22016</dc:subject>
<dc:subject>^d804^s22012</dc:subject>
<dc:subject>^d920^s22000</dc:subject>
<dc:subject>^d33766^s22027</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>201405</dc:date>
</metadata>
</record>
</ibecs-document>
